Proteomics is the study of functions and structures of proteins. Market players have been taking various steps to advance the research and development activities in the field of proteomics.
Proteomics Market Overview:
Proteomics is the study of functions and structures of proteins. Market players have been taking various steps to advance the research and development activities in the field of proteomics. Acquisition is one of the major strategies adopted by market players for combining expertise of acquired company and take strides in the market. The collaboration activities have also been taking place to develop targeted proteomic solutions and overcome the toughest analytical challenges. The demand for targeted proteomics will increase in the coming years. According to the report published by Allied Market Research, the global proteomics market is estimated to reach $49.97 billion by 2027. Following are some of the activities taking place across the world.
The trend of acquisition has taken place as it helps companies in enhancing their offerings by acquiring the expertise and resources of other company. Bruker Corporation acquired the Danish company PepSep for optimizing nanoflow proteomics workflows. These workflows are utilized in nanoElute® UHPLC system of Bruker. PepSep innovated the columns that can lower down post-column eluent mixing. This innovation has been influential in offering great nanoLC performance with the help of a standard connector. This enables robust performance and ease-in-use during exchanging columns. The acquisition will help Bruker in enhancing its products and raise their stake in the market by attracting new customers for their products. Both companies will combine their expertise and develop chemistries that would offer enhancements for 4D-proteomics applications.
Impact of COVID-19 Pandemic on Proteomics Market (Pre & Post Analysis)
In addition, the COVID-19 outbreak is expected to have an advantageous effect at the proteomics market. A massive range of clinics and hospitals throughout the globe had been restructured to boom the clinic ability for sufferers identified with COVID-19. The non-important methods took an ability backlog because of unexpectedly growing COVID-19 cases. The lockdown brought about the disruption of producing and transportation of healthcare essentials. Moreover, different elements liable for the effect available in the marketplace consist of constrained availability of clinical care, scarcity of healthcare personnel and upward push in burden of COVID-19 associated hospitalization.
Along with acquisitions, collaboration is another strategy adopted by market players for developing impactful and innovative applications. MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. collaborated for advancing the capabilities of proteomic applications. These applications will help scientific and research communities in making new discoveries. The collaboration activity is aimed at offering a complete solution for quantitative protein along with metabolite analysis. MRMP’s experience in metabolite and peptide quantitation is combined with expertise and mass spectrometry technology for development of novel tools and advancement in technologies in the field of proteomics. MRMP developed array kits for protein quantitation in research and clinical samples by integrating reliable and sensitive HPLCs of Agilent.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/1677
Top Leading Players:
- Agilent Technologies Inc.
- Danaher Corporation
- LI-COR, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- HORIBA, Ltd.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- General Electric (GE)
- Waters Corporation
Through the collaboration, MRMP will develop kits for Agilent/Evosep platform. The kits include disease specific kits and biological pathways that can be utilized in the field of proteomics. Jennifer Gushue, the Associate Vice President for Mass Spectrometry Marketing, highlighted that the novel proteomics workflows have been developed with collaboration with Evosep and MRM Proteomics. These workflows will enhance the protein quantification in clinical research and speed up the drug development in the environments that have limited samples.